Call Us Today: 1-877-SHEIN-LAW (1-877-743-4652)

← Older posts Newer posts →

Philadelphia Mesothelioma Lawyers: Discuss Threat of Asbestos in Schools

Asbestos use has declined sharply since the 1970s, when it was discovered that inhaling or ingesting asbestos fibers causes mesothelioma and  other devastating diseases like lung cancer. However, the fire-retardant mineral can still be found in older buildings and schools throughout the United States. Legislative measures are in place to protect current students, faculty, and

» Read More...
Posted on

Philadelphia Asbestos Lawyers Report on Recent U.S. Steel Violations

The Occupational Safety and Health Administration (OSHA) is fining U.S. Steel Corp. for endangering employees by exposing them to asbestos. The fines, which total $170,000, come after months of investigation into practices at its Clairton Coke Works plant. This is the second time since 2011 that the company has been fined for these violations. The

» Read More...
Posted on

Philadelphia Asbestos Lawyers: Comedian Addresses Mesothelioma in Comedy Routine

A California man diagnosed with mesothelioma is not letting his ailment stop him from doing what he loves, stand-up comedy. In 2015, doctors told Quincy Jones, a 32-year-old comedian, that he was diagnosed with mesothelioma and had under a year to live. A rare cancer linked to asbestos exposure, mesothelioma is particularly deadly and can

» Read More...
Posted on

Philadelphia Mesothelioma Lawyers Discuss Asbestos Exposure in the Navy

Asbestos is a fiber that was used extensively in construction in the first half of the twentieth century. In the 1960s, scientists discovered that inhaling asbestos particles causes mesothelioma, a rare form of cancer affecting the lining of the lungs and chest cavity, as well as other deadly diseases. Although its use has declined, asbestos

» Read More...
Posted on

Philadelphia Asbestos Lawyers: New Immunotherapy for Pleural Mesothelioma

There’s good news from Geneva for patients suffering from malignant pleural mesothelioma. In a recent presentation at the European Lung Cancer Conference in Geneva, Switzerland, researchers reported success with a new immunotherapy program that combines live bacterium with traditional chemotherapy. Doctors involved in the study reported a 90% rate of illness control and a 59%

» Read More...
Posted on

Philadelphia Mesothelioma Lawyers Discuss Promising New Treatment Method

Mesothelioma, a rare form of cancer caused by asbestos exposure, is notoriously difficult to treat. The deadly disease is resistant to many common cancer treatments, including many cancer drugs. Researchers are finding, however, that the key to mesothelioma survival may not be one treatment, but a combination of treatments. Combination therapy is showing promising results

» Read More...
Posted on

Philadelphia Mesothelioma Lawyers: Early Detection Tool for Mesothelioma

Mesothelioma, the type of cancer that affects the mesothelium commonly associated with prolonged exposure to asbestos, is also characterized by its long latency period. Mesothelioma symptoms can take up to 50 years following an individual’s exposure to manifest, which is often long after the individual retired from the career where he or she was exposed

» Read More...
Posted on

2016 Bud Cuthbert Golf Classic

The Benjamin Shein Family Foundation is proud to have sponsored the fifth annual Bud Cuthbert Golf Classic, an event to honor the life of Bud Cuthbert. The day included lunch and golf, followed by dinner with cocktails. The proceeds of the event went to the Bud Cuthbert Research and Patient Care Fund at the Abramson

» Read More...
Posted on

Philadelphia Asbestos Lawyers: University of Pennsylvania Grant for Cancer Research

Sean Parker, billionaire technology whiz and creator of the Parker Foundation, recently announced that he would be donating $250 million in grant money to six leading research centers – including the University of Pennsylvania – in an effort to accelerate the development of revolutionary cancer treatments. The Parker Foundation for Cancer Immunotherapy prioritizes the sharing

» Read More...
Posted on

Philadelphia Asbestos Lawyers Discuss Costly Cancer Drug

An Australian man is struggling to pay for the treatments that could save his life. In addition to battling mesothelioma, a rare and deadly cancer, the 59 year-old is now battling with the Pharmaceutical Benefits Scheme to get coverage for Keytruda, a drug that could help extend his life expectancy. Currently, the drug is not

» Read More...
Posted on